Ashish Misra

Employment

• Indian Institute of Technology Hyderabad Associate Professor

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis
  Technology in Cancer Research & Treatment 2026 DOI: 10.1177/15330338261424322
  +Save
• Self‐Assembled Metal‐Polyphenol Colchicine Nanoparticles Targeting Oxidative Stress and Inflammation for Treatment of Atherosclerosis
  Angewandte Chemie 2026 DOI: 10.1002/ange.202514547
  +Save
• Self‐Assembled Metal‐Polyphenol Colchicine Nanoparticles Targeting Oxidative Stress and Inflammation for Treatment of Atherosclerosis
  Angewandte Chemie International Edition 2026 DOI: 10.1002/anie.202514547
  +Save
• Long non-coding RNAs in B-cell acute lymphoblastic leukemia: Disease implication, challenges and therapeutic opportunities
  Non-coding RNA Research 2026 DOI: 10.1016/j.ncrna.2025.09.005
  +Save
• Biomimetic Nanoparticle Delivering Colchicine to Target Endothelial Inflammation for Atherosclerosis Treatment
  Advanced NanoBiomed Research 2026 DOI: 10.1002/anbr.202600004
  +Save
• Ubiquitin signatures on aggregating proteins in neurodegeneration
  Essays in Biochemistry 2025 DOI: 10.1042/ebc20253046
  +Save
• Clinical data investigation identifies MARK3 as an oncogenic driver in castration-resistant prostate cancer
  Biochemistry and Biophysics Reports 2025 DOI: 10.1016/j.bbrep.2025.102003
  +Save
• Insulin‐Like Growth Factor 2 mRNA‐Binding Protein 2 (IGF2BP2) Promotes Castration‐Resistant Prostate Cancer Progression by Regulating AR‐V7 mRNA Stability
  Cancer Reports 2025 DOI: 10.1002/cnr2.70096
  +Save
• Widespread Prevalence of CD19 Exon 5-6 Skipping In Indian Pediatric B-cell Acute Lymphoblastic Leukemia Patients
  2024 DOI: 10.1101/2024.10.15.618619
  +Save
• AR-V7 expression facilitates accelerated G2/M phase transition in castration-resistant prostate cancer
  Experimental Cell Research 2024 DOI: 10.1016/j.yexcr.2024.114026
  +Save